…o accumulation or treatment-related deaths observed.Conclusions ICI rechallenge may offer favorable clinical benefit and acceptable…
ICI
This drug is selected. Its supporting articles are shown below.
Articles mentioning ICI
40 articles · page 2 of 4…inical outcomes in patients with aNSCLC treated with first-line ICI±CHT.…
…3W IV starting day 1, Trans-arterial Tirapazamine embolization (TATE) on Days 8, 29 and on demand to achieve optimal tumor necrosis …
…nd provide tumor control when administered therapeutically with ICI. Thus, oral delivery of Lm-based cancer vaccines coupled with I…
…ted human breast cancer. Blocking myeloid cell recruitment with navaraxin (CXCR1/2 inhibitor) improved ICI responses, further suppressing…
….Conclusions These results highlight the potential of targeting DKK1 in combination with ICI therapies, to enhance NK cells activati…
… of neurological sequelae among long-term n-irAE survivors, and ICI rechallenge might be safe in n-irAE patients who have fully rec…
…iology suggests that synchronizing immune checkpoint inhibitor (ICI) dosing with morning peaks in immune activation could improve c…
…city, with G3/4 events reported in 22% compared with 14% in the nivolumab monotherapy arm. An update presented at the European Society of…
… splenocytes. In vivo, tumor-bearing mice received intratumoral OAd.shDNMT1, systemic decitabine, or immune checkpoint inhibitors (anti-Pro…
…The unique mechanism of action of immune checkpoint inhibitors (ICI) can lead to auto-inflammatory events, potentially involving an…
…Chevreau C, Penel N, Bertucci F, Toulmonde M, Bellera C, et al. Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a ph…